These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24018803)

  • 21. Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer.
    Wu M; Wei W; Xiao X; Guo J; Xie X; Li L; Kong Y; Lv N; Jia W; Zhang Y; Xie X
    Med Oncol; 2012 Dec; 29(5):3240-9. PubMed ID: 22661383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.
    Tseng RC; Lee CC; Hsu HS; Tzao C; Wang YC
    Neoplasia; 2009 Aug; 11(8):763-70. PubMed ID: 19649206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma.
    Ebru T; Fulya OP; Hakan A; Vuslat YC; Necdet S; Nuray C; Filiz O
    Int Braz J Urol; 2017; 43(3):440-454. PubMed ID: 27583351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-dependent prognostic value of body mass index for non-metastatic clear cell renal cell carcinoma: A large multicenter retrospective analysis.
    Byun SS; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Kim YJ; Lee WK
    J Surg Oncol; 2018 Jul; 118(1):199-205. PubMed ID: 29949668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma.
    Li C; Liao J; Wu S; Fan J; Peng Z; Wang Z
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):511-517. PubMed ID: 29106957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Kim SH; Kim JH; Yu EJ; Lee KW; Park CK
    Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Balance between SIRT1 and DBC1 expression is lost in breast cancer.
    Sung JY; Kim R; Kim JE; Lee J
    Cancer Sci; 2010 Jul; 101(7):1738-44. PubMed ID: 20412117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.
    Pan D; Xu L; Liu H; Zhang W; Liu W; Liu Y; Fu Q; Xu J
    Cancer Sci; 2015 May; 106(5):592-7. PubMed ID: 25702890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of CXC chemokine receptor 6 associates with poor prognosis in patients with clear cell renal cell carcinoma.
    Chang Y; Zhou L; Xu L; Fu Q; Yang Y; Lin Z; Xu J
    Urol Oncol; 2017 Dec; 35(12):675.e17-675.e24. PubMed ID: 28918166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DBC1 functions as a tumor suppressor by regulating p53 stability.
    Qin B; Minter-Dykhouse K; Yu J; Zhang J; Liu T; Zhang H; Lee S; Kim J; Wang L; Lou Z
    Cell Rep; 2015 Mar; 10(8):1324-34. PubMed ID: 25732823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study.
    Ingels A; Hew M; Algaba F; de Boer OJ; van Moorselaar RJ; Horenblas S; Zondervan P; de la Rosette JJ; Pilar Laguna Pes M
    World J Urol; 2017 Jan; 35(1):81-87. PubMed ID: 27207480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma.
    Cho DS; Joo HJ; Oh DK; Kang JH; Kim YS; Lee KB; Kim SJ
    Yonsei Med J; 2005 Feb; 46(1):133-40. PubMed ID: 15744816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma.
    Yang L; Liu Y; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
    Ann Surg Oncol; 2016 Mar; 23(3):1044-52. PubMed ID: 26467457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor.
    Xia Y; Liu L; Xiong Y; Bai Q; Wang J; Xi W; Qu Y; Xu J; Guo J
    BMC Cancer; 2017 Jan; 17(1):70. PubMed ID: 28114889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment.
    Wenhui Z; Shuo L; Dabei T; Ying P; Zhipeng W; Lei Z; Xiaohui H; Jingshu G; Hongtao S; Qingyuan Z
    Eur J Endocrinol; 2014 Oct; 171(4):527-33. PubMed ID: 25069458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma.
    Zhang ZY; Hong D; Nam SH; Kim JM; Paik YH; Joh JW; Kwon CH; Park JB; Choi GS; Jang KY; Park CK; Kim SJ
    J Hepatol; 2015 Jan; 62(1):121-30. PubMed ID: 25131770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD151 expression can predict cancer progression in clear cell renal cell carcinoma.
    Yoo SH; Lee K; Chae JY; Moon KC
    Histopathology; 2011 Jan; 58(2):191-7. PubMed ID: 21323946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-metastatic clear cell renal carcinoma: prognostic significance of morphometric and biomolecular factors].
    Iurin AG
    Vopr Onkol; 2009; 55(2):177-82. PubMed ID: 19514371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel marker ADAM17 for clear cell renal cell carcinomas: implication for patients' prognosis.
    Li G; Forest F; Feng G; Gentil-Perret A; Péoc'h M; Cottier M; Mottet N
    Urol Oncol; 2014 Nov; 32(8):1272-6. PubMed ID: 24996774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.